Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Linda Danielli
Observed name:
L. Danielli
Institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Genoa,
University of Bologna
ORCID:
0000-0002-9143-8096
Observed ORCID:
0000-0002-9143-8096
OpenAlex ID:
A5010239255
Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis
2022
·
G. Nader-Marta
, D. Martins-Branco
, et al.
·
ESMO Open
·
26
PDF
State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes
2024
·
Elisa Tassinari
, Linda Danielli
, et al.
·
Human Vaccines & Immunotherapeutics
·
16
Pathological and Clinical Implications of Tumor Microenvironment Evaluated With Multiplex Immunohistochemistry in Testicular Embryonal Carcinoma
2025
·
Valentina Tateo
, Costantino Ricci
, et al.
·
Clinical Genitourinary Cancer
·
6
Current androgen receptor antagonists under investigation for resistant prostate cancer: progress and challenges
2025
·
Linda Danielli
, Elisa Tassinari
, et al.
·
Expert Review of Anticancer Therapy
·
6
177Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study
2025
·
Philipp Mandel
, Daniel Groener
, et al.
·
European Journal of Cancer
·
5
Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience
2025
·
Matteo Rosellini
, Veronica Mollica
, et al.
·
Pathology - Research and Practice
·
4
KIM-1 and beyond: emerging biomarkers for adjuvant immunotherapy in clear cell renal cell carcinoma
2026
·
Matteo Rosellini
, Linda Danielli
, et al.
·
Expert Review of Molecular Diagnostics
·
3
The Prognostic Role of 68GA-PSMA-PET/CT in Metastatic Hormone-Sensitive Prostate Cancer: A Preliminary Analysis
2025
·
Andrea Marchetti
, Veronica Mollica
, et al.
·
Clinical Genitourinary Cancer
·
3
Efficacy of Adding Immune Checkpoint Inhibition to Chemotherapy, With or Without VEGF Inhibition, in Patients With Advanced EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis With Reconstructed Individual Patient Data
2026
·
Alessandro Di Federico
, Sara Stumpo
, et al.
·
JTO Clinical and Research Reports
·
1
The value of molecular features in predicting efficacy of immuno-combinations in kidney cancer: just a drop in the ocean?
2025
·
Matteo Rosellini
, Elisa Tassinari
, et al.
·
Expert Review of Molecular Diagnostics
·
1
Efficacy and safety of nivolumab in pretreated patients with metastatic squamous cell carcinoma of anus: A real-world experience.
2024
·
Nicole Conci
, Fabiola Lorena Rojas Llimpe
, et al.
·
Journal of Clinical Oncology
·
1
The impact of neoadjuvant chemotherapy relative dose intensity on pathological complete response and survival in muscle-invasive urothelial cancer: A multicentric retrospective study.
2026
·
Giuseppe Neola
, Fabiano Flauto
, et al.
·
Journal of Clinical Oncology
Advancements of investigational agents for renal cell carcinoma: what clinical progress have we seen in the last 5 years?
2025
·
Linda Danielli
, Matteo Rosellini
, et al.
·
Expert Opinion on Investigational Drugs
Show more works
View as search
Works count:
13
Citation count:
72
H-index:
5
I10-index:
2
Year
Topic
Type